Quick Answer
Centessa Pharmaceuticals plc reported Earnings Per Share Diluted of $1.46 (loss) per share for the year ending 2025.
- Centessa Pharmaceuticals plc showed an increase of +29.1% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Centessa Pharmaceuticals plc's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Centessa Pharmaceuticals plc's Earnings Per Share Diluted has grown by 71.2%.
- Historical annual values: Fiscal year 2025: $1.46 (loss) per share | Fiscal year 2024: $2.06 (loss) per share | Fiscal year 2023: $1.57 (loss) per share | Fiscal year 2022: $2.31 (loss) per share | Fiscal year 2021: $5.07 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: